Clinical Trial Nuedexta in Subjects With ALS

Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2013
Cargando información sobre las referencias
The purpose of this study is to determine whether Nuedexta is effective in the treatment of symptoms (impaired speech, swallowing, and saliva control)associated with Amyotrophic Lateral Sclerosis (ALS).
Epistemonikos ID: 37466f021febecb282de15dfa54c4be7f7b94093
First added on: Nov 02, 2022